Clinical Trials Logo

Mucinous Breast Cancer clinical trials

View clinical trials related to Mucinous Breast Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT03201861 Recruiting - Clinical trials for Mucinous Breast Cancer

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Start date: July 27, 2017
Phase: Phase 3
Study type: Interventional

The investigators hypotheses that paclitaxel combined with cisplatin in a weekly-based regimen as adjuvant chemotherapy is more effective for high risk, HER2 negative breast cancer .

NCT ID: NCT02879513 Recruiting - Clinical trials for Inflammatory Breast Cancer

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

Start date: January 2014
Phase: Phase 3
Study type: Interventional

This trial will compare the administration of 2 cycles of paclitaxel and cisplatin (DP) versus 4 cycles of CEF as adjuvant chemotherapy for the patients with locally advanced breast cancer and who were pathological partial response to DP as neoadjuvant chemotherapy. Those who had pathological complete response to DP will be randomized to have 2 cycles of DP or have no further chemotherapy.

NCT ID: NCT02221999 Recruiting - Clinical trials for Inflammatory Breast Cancer

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

SHPD002
Start date: January 2014
Phase: Phase 2/Phase 3
Study type: Interventional

The investigators hypothesize that paclitaxel combined with cisplatin in a weekly-based regimen as neoadjuvant chemotherapy is effective and tolerable for locally advanced breast cancer. In patients with some sub-type advanced breast cancer, neo-adjuvant chemotherapy combined with endocrine therapy may improve the pathological remission rate. Premenopausal patients with triple negative breast caner and hormonal receptor positve breast cancer patients will be randominzed to have neoadjuvant chemotherapy combined with endocrine therapy or not.

NCT ID: NCT02199418 Completed - Clinical trials for Inflammatory Breast Cancer

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

SHPD001
Start date: January 2013
Phase: Phase 2
Study type: Interventional

The investigators hypotheses that paclitaxel combined with cisplatin in a weekly-based regimen as neoadjuvant chemotherapy is effective and tolerable for locally advanced breast cancer.